Holen Sie sich die Stockscreener-App
94.08
3.00%
2.74
Handel nachbörslich:
93.99
-0.09
-0.10%
Zimmer Biomet Holdings Inc Aktie (ZBH) Neueste Nachrichten
ZBH250 Bond Profile — Key Metrics - TradingView
Zimmer Biomet Holdings Inc (ZBH) Stock Up 3.0% and Still Underva - GuruFocus
Zimmer Biomet Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
Zimmer Biomet Rises as Investors Weigh Upcoming Earnings, Recent Product Activity, and Capital Return Support - Quiver Quantitative
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2026 Financial Results - Ortho Spine News
Zimmer Biomet to announce Q2 2026 results on August 5 - scanx.trade
Zimmer Biomet (ZBH) Q4 2025 earnings summary - Quartr
Zimmer Biomet to post Q2 2026 results before market, hold call at 8:30 a.m. ET - Stock Titan
Zimmer Biomet stock holds steady on a broader medtech backdrop - ad-hoc-news.de
ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now? - TradingView
Is Zimmer Biomet Stock the Right Pick for Your Portfolio Now? - Yahoo Finance UK
ZBH stock holds steady as orthopedic demand supports long term outlook - ad-hoc-news.de
Explosive Growth in AI for Orthopedic Surgery Market: $0.87 Billion by 2030 at 27.2% CAGR - GlobeNewswire Inc.
Global Orthopedic Surgical Robots Market Report Published — Profiles Stryker, Zimmer Biomet, DePuy Synthes, and Medtronic - Yahoo Finance
BMO Capital Initiates Coverage on Zimmer Biomet With Market Perform Rating, $95 Price Target - marketscreener.com
Zimmer Biomet focuses on orthopedic growth. Investors watch long-term demand - Ad-hoc-news.de
Zimmer Biomet (ZBH) Coverage Initiated with Market Perform Ratin - GuruFocus
Zimmer Biomet Holdings Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Zimmer Biomet To Acquire Iovera Pain Therapy Business For $140M - InkFreeNews.com
Citi Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating, Maintains Target Price $93 - Moomoo
Zimmer Biomet focuses on orthopedic growth as investors weigh long-term demand - AD HOC NEWS
Zimmer Biomet stock holds focus on execution - AD HOC NEWS
Evercore ISI Adjusts Price Target on Zimmer Biomet to $110 From $120 - Moomoo
Zimmer Biomet stock holds steady on thin coverage. Focus stays on execution. - AD HOC NEWS
Zimmer Biomet acquires rights to medical device for $140 million - Inside INdiana Business
Evercore Maintains Zimmer Biomet Holdings(ZBH.US) With Buy Rating, Cuts Target Price to $110 - Moomoo
JP Morgan Downgrades Zimmer Biomet Holdings (ZBH) - MSN
Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating the Potential 12.84% Upside in the Healthcare Sector - DirectorsTalk Interviews
Enterprise value to revenue forward of Zimmer Biomet Holdings, Inc. – NYSE:ZBH - TradingView
Zimmer Biomet (ZBH) Stock Looks Cheap On Earnings But Faces Growth Doubts - Sahm
Zimmer Biomet Holdings Inc (ZBH) Shares Surge 3.9% -- What GF Sc - GuruFocus
ZBH News | ZIMMER BIOMET HOLDINGS INC (NYSE:ZBH) - ChartMill
Zimmer Biomet (ZBH) director awarded 389 Phantom Stock Units in deferred pay plan - Stock Titan
[Form 4] ZIMMER BIOMET HOLDINGS, INC. Insider Trading Activity - Stock Titan
Form 4 Zimmer Biomet Holdings Inc For: 2 July By Investing.com - Investing.com India
Zimmer Biomet (ZBH) director granted 317.369 cash-settled phantom stock units - Stock Titan
Zimmer Biomet (ZBH) director awarded 317.369 phantom stock units in cash-settled plan - Stock Titan
Phantom stock grant increases Zimmer Biomet (NYSE: ZBH) director units - Stock Titan
Zimmer Biomet (NYSE: ZBH) director receives cash-settled phantom stock grant - Stock Titan
Zimmer Biomet (ZBH) director receives new phantom stock unit award - Stock Titan
Medical device maker Zimmer Biomet to hire 500 in 3 years for tech centre in India - marketscreener.com
Enterprise value to EBIT forward of Zimmer Biomet Holdings, Inc. – NYSE:ZBH - TradingView
Zimmer Biomet (ZBH) Is Buying Pacira’s Iovera Device And Expanding Into Spasticity - Yahoo Finance
Zimmer Biomet Holdings | SD: Specialized disclosure report - Moomoo
‘Cool move’ by Zimmer part of med-tech’s tuck-in deals trend - BioWorld News
Pacira to Divest iovera Business to Zimmer Biomet in Up To $140M Deal - TradingView
Pacira BioSciences to divest its iovera° business to Zimmer Biomet - Medical Buyer
Zimmer Biomet to acquire iovera device from Pacira for $140m - Yahoo Finance
BTIG Maintains Zimmer Biomet Holdings(ZBH.US) With Hold Rating - Moomoo
Persona IQ from Zimmer Biometsmart knee implant brings continuous data to US surgeons - AD HOC NEWS
A Look at Zimmer Biomet Holdings Inc (ZBH) After 5.6% Decline -- GF Value $126.11 vs Price $86.09 - GuruFocus
Zimmer Biomet Holdings, Inc.'s Stock Price Plummets to $86.09, Suffers a Sharp 5.64% Drop - Smartkarma
Zimmer Biomet Holdings Inc. stock underperforms Tuesday when compared to competitors - MSN
Zimmer Biomet Holdings, Inc. agreed to acquire iovera ° Business of Pacira BioSciences from Pacira BioSciences, Inc. for $140 million. - marketscreener.com
Why is Zimmer Biomet stock sliding today? By Investing.com - Investing.com Canada
What is behind Zimmer Biomet stock's recent drop in value today - Traders Union
Pacira BioSciences (PCRX) Sells iovera° Business to Zimmer Biome - GuruFocus
Pacira divests iovera device to Zimmer Biomet for up to $140m - Investing.com
Pacira BioSciences stock rises on Zimmer Biomet deal By Investing.com - Investing.com South Africa
Pacira BioSciences stock rises on Zimmer Biomet deal - Investing.com UK
0.49%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):